Biophore seeks DCGI approval for Aviptadil for Covid treatment

Hyderabad, June 11 (IANS) Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the...

Become a proud member of 1947.com to access this content.